Scand J Public Health 39:9194
It triggers the liver to release glucose and raise blood sugar levels, which may contribute to high blood sugar in people with type 2 diabetes
Experts also warn that longer-term health risks may involve harm to the liver, kidneys, and nervous system, particularly when people use these medicines without medical assessment, follow-up, or dosing guidance
Semaglutide is a medication used to treat two main conditions: type 2 diabetes and obesity
Besonders starker Belastung gewachsen
The primary treatment in IIH is acetazolamide, but many patients deteriorate and remain unwell despite treatment and the drug also has such severe side effects that our previous trials have shown that 48% of patients stop taking it. Obesity is the major causative risk factor for IIH 2,3 and GLP-1 agonists cause weight loss in both diabetic and non-diabetic patients